Though most biopharma investment is in two states, follow this model to bring the research—and investments—elsewhere.

Stoke Therapeutics Inc. (Nasdaq: STOK) has pulled in Biogen (Nasdaq: BIIB) to help it develop and commercialize a treatment ...

Conventional and Contemporary Practices of Plant BreedingTopics: Plant Sciences, Agriculture, Genetics and GenomicsAuthors: ...

The company has also secured a €57.5 million loan from the European Investment Bank (EIB) to advance its therapeutic cancer vaccines, extending its financial runway into the second quarter of 2026.

(RTTNews) - Purple Biotech Ltd. (PPBT), a clinical-stage company focused on developing therapies for overcoming tumor immune evasion, on Monday announced a research collaboration with the Icahn ...

--(BUSINESS WIRE)--Immunome, Inc. (“Immunome”) (Nasdaq: IMNM), a biotechnology company focused on developing ... J.P. Morgan, TD Cowen, Leerink Partners and Guggenheim Securities acted as joint ...

Tune Therapeutics, a Durham biotechnology startup co-founded by ... The company will use the funding to advance clinical trials for Tune-401, the epigenetic silencing drug for treating chronic ...

Nevertheless, confidence in Seattle’s biotech future remains strong, experts said, because of the advances in medicine by its researchers and companies. “The science and technology driving ...

The findings have been published today (29 January) in the journal Science Advances. Predicting the dynamics of turbulent fluid flows has long been a central goal for scientists and engineers.